ClinConnect ClinConnect Logo
Search / Trial NCT06935695

Surveillance Versus Bronchoscopy After Airway Stenting

Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Apr 11, 2025

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

Airway Stent Bronchoscopy Surveillance

ClinConnect Summary

This clinical trial is looking at two different ways to monitor patients who have received bronchial stents, which are small tubes placed in the airways to keep them open. The study is comparing regular check-up procedures called surveillance bronchoscopy with no additional monitoring after the stent is placed. The goal is to see if one method is better than the other in keeping patients healthy after they have had this procedure.

To be eligible for this trial, participants must be adults who need stenting in their central airways, which includes the trachea and main bronchi. Unfortunately, those who cannot understand or consent to the study due to mental health issues, those with certain types of stents, or patients who are very ill and cannot handle follow-up procedures are not able to participate. If someone joins the study, they will receive either the standard follow-up care or no extra monitoring, and researchers will carefully track their health outcomes to determine the best approach for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All adult patients that undergo central airway (trachea, main stem bronchi and bronchus intermedius) stenting.
  • Exclusion Criteria:
  • Inability to obtain informed consent due to cognitive, neurologic or psychiatric impairment.
  • Lobar or segmental stents alone
  • Terminally ill patients considered too sick to undergo a follow-up surveillance bronchoscopy
  • Stent insertion as a trial for excessive central airway collapse (as the duration of these stents is only 1-2 weeks)
  • Patients with a tracheostomy (as these patients can undergo frequent in-line suctioning that can affect the outcomes being assessed)

About Icahn School Of Medicine At Mount Sinai

The Icahn School of Medicine at Mount Sinai is a premier academic institution located in New York City, renowned for its commitment to advancing medical research, education, and patient care. As a leading sponsor of clinical trials, the institution leverages its state-of-the-art facilities and multidisciplinary expertise to drive innovative research initiatives aimed at improving health outcomes. With a focus on translational medicine, the Icahn School of Medicine collaborates with a diverse network of researchers, clinicians, and industry partners to explore novel therapies and interventions across a wide range of medical disciplines. Its rigorous scientific approach and dedication to ethical standards position it as a trusted leader in the clinical research landscape.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Udit Chaddha, MBBS

Principal Investigator

Icahn School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported